Basic cancer research has mainly focused on mutations in cancer cells that result in either gain-of-function in oncogenes or loss-of-function in tumour-suppressor genes 1 . However, the EXTRACELLULAR MATRIX (ECM) of tumours and the non-cancerous, stromal cells within tumours also have an important i
New functions for the matrix metalloproteinases in cancer progression
β Scribed by Egeblad, Mikala; Werb, Zena
- Book ID
- 109948945
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 394 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1474-1776
- DOI
- 10.1038/nrc745
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract APβ2Ξ±, interleukinβ4 (ILβ4), Eβcadherin, fibulin 1D, p16^INK4Ξ±^, PTEN, RKIP, and S100A4 are determinants (suppressors, except for S100A4) of cancer cell invasiveness and other traits of cancer progression, which are located upstream of matrix metalloproteinases (MMPs) in cell signaling
We observed previously that each of seven cancer progression inhibitors suppresses the mRNA expression of some matrix metalloproteinases (MMPs), but stimulates that of others, in breast cancer cells. In the present study we tested the effect of overexpressing other cancer modulators on MMP expressio
studies on MMP-2 in PCa patients, we question the usefulness of pro-MMP-2 measurements in blood as a suitable predictor of the progression of prostate cancer. Sincerely yours,